SENSUS HEALTHCARE, INC. | |||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||
(unaudited) | |||||||
For the Three Months Ended | |||||||
March 31, | |||||||
2019 | 2018 | ||||||
Revenues | $ | 5,436,599 | $ | 5,955,462 | |||
Cost of Sales | 2,120,621 | 2,015,200 | |||||
Gross Profit | 3,315,978 | 3,940,262 | |||||
Operating Expenses | |||||||
Selling and marketing | 2,530,346 | 2,214,911 | |||||
General and administrative | 1,013,162 | 1,342,253 | |||||
Research and development | 1,965,507 | 1,497,618 | |||||
Total Operating Expenses | 5,509,015 | 5,054,782 | |||||
Loss From Operations | (2,193,037) | (1,114,520) | |||||
Other Income (Expense) | |||||||
Interest income | 72,020 | 22,022 | |||||
Interest expense | — | (33,415) | |||||
Other Income (Expense), net | 72,020 | (11,393) | |||||
Net Loss | $ | (2,121,018) | $ | (1,125,913) | |||
Net Loss per share – basic and diluted | $ | (0.13) | $ | (0.08) | |||
Weighted average number of shares used in computing net loss per share – basic and diluted | 16,119,726 | 13,331,553 | |||||
